FLI1 and neoplasm: Mechanistically, CBL0137 significantly reduced mitotic activity and induced tumor cell death by targeting the EWSR1-FLI1-FACT pathway and disrupting the transcription of EWSR1-FLI1, SSRP1 (structure-specific recognition protein 1), and their downstream effectors.